Search the Knowledge Hub Archive
Why MedTech companies are rethinking the ‘house of brands’ model
Many MedTech companies are rethinking the house of brands model as portfolios become more complex through platforms, digital ecosystems, and long-term partnerships. A stronger masterbrand can help scale trust across the portfolio, simplify complexity, and support adoption of new technologies and services.
DeviceTalks Boston, 2026
We are delighted to be attending DeviceTalks Boston from 27–28 May 2026. Kristy Beede, Research Director, and Nicole Levin, Associate Director, will be representing Purdie Pascoe at the event.
Data, Data, Data: Why innovation is the quiet force behind great research
Behind every great research project is a system quietly keeping thousands of data points accurate, scalable, and insight ready. In this article, our Programming & Analytics experts explore how automation and innovation are transforming large-scale market research, freeing researchers to focus on what matters most: delivering meaningful insight.
SAGES Conference 2026: Connect to purpose
After attending the Society of American Gastrointestinal and Endoscopic Surgeons Conference up the road in sunny Tampa, FL, it was easy to see why this year’s theme, connect to purpose, was so fitting. Across lectures, panels, posters, and exhibits, a consistent narrative emerged: surgeons, KOLs, engineers, and medical device manufacturers are deeply aligned in a shared mission to improve patient outcomes and elevate provider experience.
ACC Conference 2026: Cardiology at a turning point
After attending the American College of Cardiology (ACC) Conference 2026, Molly Hines and Supreet Kaur reflected on their key takeaways from the event. At ACC, much of the discussion was shaped by how artificial intelligence is increasingly being embedded into clinical practice, workflows, and healthcare systems.
Cracking complex MedTech decisions: How SIMALTO reveals what truly drives stakeholder choice
In this webcast our specialists Sabera Hyderally, Head of US MedTech and Kristin Lovallo, Director, will share how this advanced methodology can uncover deeper insights, helping organizations prioritize product features, refine value propositions, and make more confident strategic decisions.
Why qualitative research matters in MedTech (and why it’s often undervalued)
Behavioural economics has long highlighted the importance of context. Data without context will only get you so far. MedTech companies need to understand why clinicians behave the way they do, how decisions actually get made inside hospitals, what ‘risk’ really means to different stakeholders and where friction exists within workflows, perceptions and emotions.
American College of Cardiology Conference 2026
We are delighted to be attending the ACC Annual Conference from March 28–30 in New Orleans, Louisiana. Senior Research Executives Molly Hines and Supreet Kaur will be representing Purdie Pascoe at the event.
The Society of American Gastrointestinal and Endoscopic Surgeons
We are delighted to be attending the SAGES Annual Conference from March 25–28 in Tampa, Florida. Kristin Lovallo, US Research Director, will be representing Purdie Pascoe at the event.
How we used a staged qualitative approach to help inform the development of a portfolio of novel digital solutions for GI endotherapy
Find out how we used a staged qualitative approach to help our client understand the landscape of digital solutions in GI endotherapy with a focus on AI, data management (clinical and non-clinical), workflow, and supply management.
Beyond the booth: Turning MedTech conferences into strategic intelligence
It already feels like we’re flying through 2026, and the next wave of major MedTech conferences is coming into view fast. Calendars are filling, budgets are being committed, and plans are taking shape. The question is no longer whether to attend, but whether your conference research strategy is truly ready?
The Global Shift in Real-World Evidence: Insights from MedTech Industry Leaders
Real-World Evidence (RWE) is playing an increasingly important role in global MedTech regulatory decision-making, supporting evidence generation across the product lifecycle, from pre-market submissions to post-market surveillance. Watch this webcast which features industry experts to understand how MedTech manufacturers can build effective, compliant RWE strategies.
Purdie Pascoe’s Primary Market Research team
Our primary market research team combines deep expertise with a full range of qualitative and quantitative techniques, including the latest digital approaches with a wealth of experience across medical devices, digital healthcare, drug delivery, precision medicine and diagnostics.
Smarter workflows, sharper insights: How our dedicated Innovation team helps us (and our clients) work better
Innovation sits right at the intersection of data, technology, and research. Our Innovation team’s goal is simple: make complex studies easier to run, insights easier to find, and decisions easier to make, for both our research colleagues and our clients.
Movember in Motion: Internal study about how our people think about health and fitness
Have you ever wondered what really makes your employees tick when it comes to their health and wellbeing? What drives them to move, eat well, switch off mentally or what silently holds them back? Each November, millions join Movember to spark conversation and action around men’s physical and mental health. At Purdie Pascoe, we’ve taken part for the last few years. But this year, we wanted to go a step further. Instead of just looking outward, we turned the lens on ourselves.
Spotlight on a year in review at Purdie Pascoe
As we all start to get into the festive spirit ahead of the holiday season, it’s a perfect time to reflect on achievements, and of course challenges across the past year. 2025 has been a big year for Purdie Pascoe, and in this short interview, Co-Founder Guy Pascoe provides insight into what has made this year so pivotal for the business.
Spotlight on why no longer just PMCF
Our dedicated division has evolved. While PMCF remains a core part of our offering, we’re now applying our expertise to broader areas, including other forms of Real World Data (RWD) collection and Post Market Performance Follow-Up (PMPF). In this conversation, Marcus and Ellie discuss the why behind the expansion of our services, the evolution of the team, and what it means for our clients at Purdie Pascoe.
Four rules for smarter ad testing in medical device marketing
Beneath the white coats, doctors are still human. They respond to good stories, authentic visuals, and messages that feel credible and relevant. At Purdie Pascoe, ad testing continues to be one of the most revealing parts of our work, helping medical device manufacturers understand not just what their audiences say they want, but what they actually respond to.
The MedTech Difference: Insights from Industry Leaders
Sabera Hyderally, Purdie Pascoe’s Head of US MedTech, recently facilitated an engaging, honest, and thought-provoking conversation with experts from across the MedTech and Diagnostics industry. The discussion explored how MedTech differs from other sectors, particularly pharmaceuticals, and what these differences mean for how we approach market research, innovation, and patient engagement.
Purdie Pascoe global meeting 2025: MedTech, sunshine & the usual quiz night drama
With over 50 of us now based across the UK, US, and Europe, this year’s meeting was a true celebration of our growth, our people, and our commitment to MedTech. Fittingly, our theme this year was bold and simple: MedTech, as it’s not just one of our sectors - it’s our sole focus.